Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/13963
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSilva, Carolina Lazzarotto-
dc.contributor.authorBinato, Renata-
dc.contributor.authorRocher, Ba´rbara Du-
dc.contributor.authorCosta, Júlia Assunção Costa e-
dc.contributor.authorPizzatti, Luciana-
dc.contributor.authorBouzas, Luis Fernando da Silva-
dc.contributor.authorAbdelhay, Eliana Saul Furquim Werneck-
dc.date.accessioned2023-05-26T18:43:25Z-
dc.date.available2023-05-26T18:43:25Z-
dc.date.issued2009-
dc.identifier.issn1477-2566-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/13963-
dc.description.abstractBone marrow (BM) stromal cells, also referred to as mesenchymal stromal cells (MSC), can be expanded ex vivo and are able to differentiate along multiple lineages, including chondrocytes, osteoblasts and adipocytes. MSC are known to secrete a number of cytokines and regulatory molecules implicated in different aspects of hematopoiesis, and seem to modulate the immune system. MSC appear to be promising candidates for cellular therapy associated with BM transplantation (BMT). Methods We compared protein expression profiles of MSC cultures derived from different BM donors using two-dimensional (2-D) gel electrophoresis and matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) tandem mass spectrometry (MS/MS), and compared mixed lymphocyte reaction (MLR) assays in the absence and presence of third-party human (h) MSC derived from different donors during the same culture passage. Results In a window of observation (pH 4 7, molecular weight 10 220 kDa), about 172 protein spots were obtained in each 2-D gel, corresponding to 84 distinct proteins. A comparative analysis demonstrated a very similar proteomic profile of cells of the first passage derived from different donors, suggesting that these cells have the same expression pattern. Additionally, cells derived from different donors were equally able to inhibit lymphocyte proliferation. Conclusions These results encourage the use of third-party MSC in cellular therapies, as cells derived from different individuals seem to have the same proteomic pattern and exhibit functionally similar properties.pt_BR
dc.subjectBone Marrow Transplantationpt_BR
dc.subjectTransplante de Medula Ósseapt_BR
dc.subjectImunoterapia Adotivapt_BR
dc.subjectImmunotherapy Adoptivept_BR
dc.subjectCélulas-Tronco Mesenquimaispt_BR
dc.subjectMesenchymal Stem Cellspt_BR
dc.subjectProteomapt_BR
dc.subjectProteomept_BR
dc.subjectCélulas Estromaispt_BR
dc.subjectStromal Cellspt_BR
dc.subjectProteômicapt_BR
dc.subjectProteomicspt_BR
dc.subjectEstudo de Avaliaçãopt_BR
dc.subjectEvaluation Studypt_BR
dc.subjectthird-partypt_BR
dc.subjectterceirospt_BR
dc.titleSimilar proteomic profiles of human mesenchymal stromal cells from different donorspt_BR
dc.TypeArticlept_BR
Appears in Collections:Hospital do Câncer I (HCI)



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.